Clinical Trials · NCT01861717

A Pilot Study of Pre- and Post-operative Use of Somatuline Depot.

TerminatedPhase 4Lanreotide (Prohibited)
Phase
Phase 4
Recruitment status
Terminated
Sponsor
Saint John's Cancer Institute
Enrollment
4
Start date
May 2013
Locations
1 site, United States
Primary endpoint
Early Remission of Acromegaly
View Lanreotide compound reference